394
Views
17
CrossRef citations to date
0
Altmetric
Research Articles

Computational investigations of gram-negative bacteria phosphopantetheine adenylyltransferase inhibitors using 3D-QSAR, molecular docking and molecular dynamic simulations

, , &
Pages 1435-1447 | Received 23 Dec 2018, Accepted 10 Apr 2019, Published online: 30 Apr 2019

References

  • Amin, S. A., Adhikari, N., Jha, T., & Ghosh, B. (2018). Designing potential HDAC3 inhibitors to improve memory and learning. Journal of Biomolecular Structure and Dynamics, 37, 2133–2142. doi:10.1080/07391102.2018.1477625
  • Banks, J. L., Beard, H. S., Cao, Y., Cho, A. E., Damm, W., Farid, R., … Levy, R. M. (2005). Integrated Modeling Program, Applied Chemical Theory (IMPACT). Journal of Computational Chemistry, 26(16), 1752–1780. doi:10.1002/jcc.20292
  • Begley, T. P., Kinsland, C., & Strauss, E. (2001). The biosynthesis of coenzyme A in bacteria. Vitamins and Hormones, 61, 157–171.
  • Bowers, K. J., Chow, E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., … Sacerdoti, F. D. (2006). Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters. In Proceedings of the ACM/IEEE SC 2006 Conference (pp. 43–43).
  • Cheng, P., Li, J., Wang, J., Zhang, X., & Zhai, H. (2018). Investigations of FAK inhibitors: A combination of 3D-QSAR, docking, and molecular dynamics simulations studies. Journal of Biomolecular Structure and Dynamics, 36(6), 1529–1549. doi:10.1080/07391102.2017.1329095
  • de Jonge, B. L. M., Walkup, G. K., Lahiri, S. D., Huynh, H., Neckermann, G., Utley, L., … Thresher, J. (2013). Discovery of inhibitors of 4′-phosphopantetheine adenylyltransferase (PPAT) to validate PPAT as a target for antibacterial therapy. Antimicrobial Agents and Chemotherapy, 57(12), 6005–6015. doi:10.1128/AAC.01661-13
  • Dowlati Beirami, A., Hajimahdi, Z., & Zarghi, A. (2018). Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors. Journal of Biomolecular Structure and Dynamics, 36: 1–8. doi:10.1080/07391102.2018.1502687
  • Draenert, R., Seybold, U., Grutzner, E., & Bogner, J. R. (2015). Novel antibiotics: are we still in the pre-post-antibiotic era?. Infection, 43(2), 145–151. doi:10.1007/s15010-015-0749-y
  • Evans, J. C., Trujillo, C., Wang, Z., Eoh, H., Ehrt, S., Schnappinger, D., … Mizrahi, V. (2016). Validation of CoaBC as a bactericidal target in the coenzyme a pathway of Mycobacterium tuberculosis. ACS Infectious Diseases, 2(12), 958–968. doi:10.1021/acsinfecdis.6b00150
  • Gao, F., Wang, P., Yang, H., Miao, Q., Ma, L., & Lu, G. (2018). Recent developments of quinolone-based derivatives and their activities against Escherichia coli. European Journal of Medicinal Chemistry, 157, 1223–1248. doi:10.1016/j.ejmech.2018.08.095
  • Gapsys, V., Michielssens, S., Peters, J. H., de Groot, B. L., & Leonov, H. (2015). Calculation of binding free energies. Methods in Molecular Biology (Clifton, N.J.), 1215, 173–209. doi:10.1007/978-1-4939-1465-4_9
  • Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47(7), 1750–1759. doi:10.1021/jm030644s
  • Hung, C. L., & Chen, C. C. (2014). Computational approaches for drug discovery. Drug Development Research, 75(6), 412–418. doi:10.1002/ddr.21222
  • Jujjavarapu, S. E., & Dhagat, S. (2018). In silico discovery of novel ligands for antimicrobial lipopeptides for computer-aided drug design. Probiotics and Antimicrobial Proteins, 10(2), 129–141. doi:10.1007/s12602-017-9356-9
  • Kingwell, K. (2018). Antibacterial agents: New antibiotic hits Gram-negative bacteria. Nature Reviews Drug Discovery, 17(11), 785–785. doi:10.1038/nrd.2018.182
  • Leekha, S., Terrell, C. L., & Edson, R. S. (2011). General principles of antimicrobial therapy. Mayo Clinic Proceedings, 86(2), 156–167. doi:10.4065/mcp.2010.0639
  • Leonardi, R., Zhang, Y. M., Rock, C. O., & Jackowski, S. (2005). Coenzyme A: Back in action. Progress in Lipid Research, 44(2-3), 125–153. doi:10.1016/j.plipres.2005.04.001
  • Li, Y.-P., Weng, X., Ning, F.-X., Ou, J.-B., Hou, J.-Q., Luo, H.-B., … Gu, L.-Q. (2013). 3D-QSAR studies of azaoxoisoaporphine, oxoaporphine, and oxoisoaporphine derivatives as anti-AChE and anti-AD agents by the CoMFA method. Journal of Molecular Graphics and Modelling, 41, 61–67. doi:10.1016/j.jmgm.2013.02.003
  • Liu, X., Shi, D., Zhou, S., Liu, H., Liu, H., & Yao, X. (2018). Molecular dynamics simulations and novel drug discovery. Expert Opinion on Drug Discovery, 13(1), 23–37. doi:10.1080/17460441.2018.1403419
  • Macalino, S. J., Gosu, V., Hong, S., & Choi, S. (2015). Role of computer-aided drug design in modern drug discovery. Archives of Pharmacal Research, 38(9), 1686–1701. doi:10.1007/s12272-015-0640-5
  • Makhouri, F. R., & Ghasemi, J. B. (2019). Combating diseases with computational strategies used for drug design and discovery. Current Topics in Medicinal Chemistry, 18, 2743–2773. doi:10.2174/1568026619666190121125106
  • Melo-Filho, C. C., Braga, R. C., & Andrade, C. H. (2014). 3D-QSAR approaches in drug design: perspectives to generate reliable CoMFA models. Current Computer-Aided Drug Design, 10(2), 148–159.
  • Moreau, R. J., Skepper, C. K., Appleton, B. A., Blechschmidt, A., Balibar, C. J., Benton, B. M., … de Vicente, J. (2018). Fragment-based drug discovery of inhibitors of phosphopantetheine adenylyltransferase from gram-negative bacteria. Journal of Medicinal Chemistry, 61(8), 3309–3324. doi:10.1021/acs.jmedchem.7b01691
  • Pradhan, D., Priyadarshini, V., Munikumar, M., Swargam, S., Umamaheswari, A., & Bitla, A. (2014). Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of Leptospira spp.: homology modeling, docking, and molecular dynamics study. Journal of Biomolecular Structure and Dynamics, 32(2), 171–185. doi:10.1080/07391102.2012.758056
  • Rath, C. M., Benton, B. M., de Vicente, J., Drumm, J. E., Geng, M., Li, C., … Feng, B. Y. (2018). Optimization of CoaD inhibitors against gram-negative organisms through targeted metabolomics. ACS Infectious Diseases, 4(3), 391–402. doi:10.1021/acsinfecdis.7b00214
  • Shekhar Mishra, S., Venkatachalam, T., Shekhar Sharma, C., Pratap Singh, H., Kalra, S., & Kumar, N. (2018). Computational investigation of binding mechanism of substituted pyrazinones targeting corticotropin releasing factor-1 receptor deliberated for anti-depressant drug design. Journal of Biomolecular Structure and Dynamics, 1–39. doi:10.1080/07391102.2018.1513379
  • Shivakumar, D., Williams, J., Wu, Y., Damm, W., Shelley, J., & Sherman, W. (2010). Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field. Journal of Chemical Theory and Computation, 6(5), 1509–1519. doi:10.1021/ct900587b
  • Skepper, C. K., Moreau, R. J., Appleton, B. A., Benton, B. M., Drumm, J. E., Feng, B. Y., … de Vicente, J. (2018). Discovery and optimization of phosphopantetheine adenylyltransferase inhibitors with gram-negative antibacterial activity. Journal of Medicinal Chemistry, 61(8), 3325–3349. doi:10.1021/acs.jmedchem.7b01861
  • Spry, C., Kirk, K., & Saliba, K. J. (2008). Coenzyme A biosynthesis: An antimicrobial drug target. FEMS Microbiology Reviews, 32(1), 56–106. doi:10.1111/j.1574-6976.2007.00093.x
  • Ul-Haq, Z., Ashraf, S., & Bkhaitan, M. M. (2018). Molecular dynamics simulations reveal structural insights into inhibitor binding modes and mechanism of casein kinase II inhibitors. Journal of Biomolecular Structure and Dynamics, 37, 1120–1135. doi:10.1080/07391102.2018.1450166
  • Wang, M., Wang, Y., Kong, D., Jiang, H., Wang, J., & Cheng, M. (2018). In silico exploration of aryl sulfonamide analogs as voltage-gated sodium channel 1.7 inhibitors by using 3D-QSAR, molecular docking study, and molecular dynamics simulations. Computational Biology and Chemistry, 77, 214–225. doi:10.1016/j.compbiolchem.2018.10.009
  • Wang, T., Yuan, X. S., Wu, M. B., Lin, J. P., & Yang, L. R. (2017). The advancement of multidimensional QSAR for novel drug discovery - where are we headed?. Expert Opinion on Drug Discovery, 12(8), 769–784. doi:10.1080/17460441.2017.1336157
  • Wang, Z. Z., Yang, J., Sun, X. D., Ma, C. Y., Gao, Q. B., Ding, L., & Liu, H. M. (2018). Probing the binding mechanism of substituted pyridine derivatives as effective and selective lysine specific demethylase 1 inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 36, 1–29. doi:10.1080/07391102.2018.1518158
  • Willyard, C. (2017). The drug-resistant bacteria that pose the greatest health threats. Nature, 543(7643), 15. doi:10.1038/nature.2017.21550
  • Zhao, L., Allanson, N. M., Thomson, S. P., Maclean, J. K. F., Barker, J. J., Primrose, W. U., … Lewendon, A. (2003). Inhibitors of phosphopantetheine adenylyltransferase. European Journal of Medicinal Chemistry, 38(4), 345–349. doi:10.1016/S0223-5234(03)00047-3

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.